{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:04:02Z","timestamp":1761487442766},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1093\/intimm\/dxh305","type":"journal-article","created":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T00:34:18Z","timestamp":1124498058000},"page":"1293-1302","source":"Crossref","is-referenced-by-count":23,"title":["A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice"],"prefix":"10.1093","volume":"17","author":[{"given":"Xiangming","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,8,19]]},"reference":[{"key":"key\n\t\t\t\t20171010201144_BIB1","doi-asserted-by":"crossref","unstructured":"Lee, W. M. 1997. Hepatitis B virus infection. N. Engl. J. Med.337:1733.","DOI":"10.1056\/NEJM199712113372406"},{"key":"key\n\t\t\t\t20171010201144_BIB2","doi-asserted-by":"crossref","unstructured":"Straley, S. and Terrault, N. 2004. Overview of treatment of hepatitis B: key approaches and clinical challenges. Curr. Treat. Options Gastroenterol.7:477.","DOI":"10.1007\/s11938-004-0007-3"},{"key":"key\n\t\t\t\t20171010201144_BIB3","doi-asserted-by":"crossref","unstructured":"Pianko, S. and McHutchison, J. 1999. Chronic hepatitis B: new therapies on the horizon. Lancet354:1662.","DOI":"10.1016\/S0140-6736(99)00305-0"},{"key":"key\n\t\t\t\t20171010201144_BIB4","doi-asserted-by":"crossref","unstructured":"Michel, M.-L., Pol, S., Brechot, C. and Tiollais, P. 2001. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future. Vaccine19:2395.","DOI":"10.1016\/S0264-410X(00)00461-8"},{"key":"key\n\t\t\t\t20171010201144_BIB5","doi-asserted-by":"crossref","unstructured":"Michel, M.-L. and Loirat, D. 2001. DNA Vaccines for prophylactic or therapeutic immunization against hepatitis B. Intervirology44:78.","DOI":"10.1159\/000050035"},{"key":"key\n\t\t\t\t20171010201144_BIB6","doi-asserted-by":"crossref","unstructured":"Couillin, I., Pol, S., Mancini, M. et al.1999. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens. J. Infect. Dis.180:15.","DOI":"10.1086\/314828"},{"key":"key\n\t\t\t\t20171010201144_BIB7","unstructured":"Pol, S., Couillin, I., Michel, M. et al.1998. Immunotherapy of chronic hepatitis B by anti HBV vaccine. Acta Gastroenterol. Belg.61:228."},{"key":"key\n\t\t\t\t20171010201144_BIB8","doi-asserted-by":"crossref","unstructured":"Yalcin, K., Danis, R., Degertekin, H., Alp, M. N., Tekes, S. and Budak, T. 2003. The lack of effect of therapeutic vaccination with a Pre-S2\/S HBV vaccine in the immune tolerant phase of chronic HBV infection. J. Clin. Gastroenterol.37:330.","DOI":"10.1097\/00004836-200310000-00012"},{"key":"key\n\t\t\t\t20171010201144_BIB9","unstructured":"Swain, W., Heydenburg, F. D., Wu, M. et al.2000. Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B. Dev. Biol. (Basel)104:115."},{"key":"key\n\t\t\t\t20171010201144_BIB10","unstructured":"Roy, M. J., Wu, M. S., Barr, L. J. et al.2001. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine19:764."},{"key":"key\n\t\t\t\t20171010201144_BIB11","doi-asserted-by":"crossref","unstructured":"Mancini-Bourgine, M., Fontaine, H., Scott-Algara, D., Pol, S., Br\u00e9chot, C. and Michel, M.-L. 2004. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. Hepatology40:874.","DOI":"10.1002\/hep.20408"},{"key":"key\n\t\t\t\t20171010201144_BIB12","doi-asserted-by":"crossref","unstructured":"Fonseca, D. P. A. J., Benaissa-Trouw, B., Engelen, M. V., Kraaijeveld, C. A., Snippe, H. and Verhuel, A. F. M. 2001. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein. Infect. Immun.69:4839.","DOI":"10.1128\/IAI.69.8.4839-4845.2001"},{"key":"key\n\t\t\t\t20171010201144_BIB13","doi-asserted-by":"crossref","unstructured":"Suhrbier, A. 2002. Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes. Expert Rev. Vaccines1:207.","DOI":"10.1586\/14760584.1.2.207"},{"key":"key\n\t\t\t\t20171010201144_BIB14","doi-asserted-by":"crossref","unstructured":"Fomsgaard, A., Nielsena, H. V., Kirkbya, N. et al.1999. Induction of cytotoxic T-cell responses by gene gun DNA vaccination with minigenes encoding influenza A virus HA and NP CTL-epitopes. Vaccine18:681.","DOI":"10.1016\/S0264-410X(99)00279-0"},{"key":"key\n\t\t\t\t20171010201144_BIB15","doi-asserted-by":"crossref","unstructured":"Toes, R. E. M., Hoeben, R. C., Van der Voort, E. I. H., Ressing, M. E., Melief, C. J. M. and Offringa, R. 1997. Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion. Proc. Natl Acad. Sci. USA94:14660.","DOI":"10.1073\/pnas.94.26.14660"},{"key":"key\n\t\t\t\t20171010201144_BIB16","doi-asserted-by":"crossref","unstructured":"Bazhan, S. I., Belavin, P. A., Seregin, S. V. et al.2004. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens. Vaccine22:1672.","DOI":"10.1016\/j.vaccine.2003.09.048"},{"key":"key\n\t\t\t\t20171010201144_BIB17","doi-asserted-by":"crossref","unstructured":"Wilson, C. C., McKinney, D., Anders, M. et al.2003. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1. J. Immunol.171:5611.","DOI":"10.4049\/jimmunol.171.10.5611"},{"key":"key\n\t\t\t\t20171010201144_BIB18","doi-asserted-by":"crossref","unstructured":"Subbramanian, R. A., Kuroda, M. J., Charini, W. A. et al.2003. Magnitude and diversity of cytotoxic-T-lymphocyte responses elicited by multiepitope DNA vaccination in rhesus monkeys. J. Virol.77:10113.","DOI":"10.1128\/JVI.77.18.10113-10118.2003"},{"key":"key\n\t\t\t\t20171010201144_BIB19","doi-asserted-by":"crossref","unstructured":"Ishioka, G. Y., Hermanson, J. F. G., Livingston, B. et al.1999. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J. Immunol.162:3915.","DOI":"10.4049\/jimmunol.162.7.3915"},{"key":"key\n\t\t\t\t20171010201144_BIB20","doi-asserted-by":"crossref","unstructured":"Asea, A., Kraeft, S., Kurt-Jones, E. et al.2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med.6:435.","DOI":"10.1038\/74697"},{"key":"key\n\t\t\t\t20171010201144_BIB21","doi-asserted-by":"crossref","unstructured":"Srivastava, P. K. and Amato, R. J. 2001. Heat shock proteins: the \u2018Swiss Army Knife\u2019 vaccines against cancers and infectious agents. Vaccine19:2590.","DOI":"10.1016\/S0264-410X(00)00492-8"},{"key":"key\n\t\t\t\t20171010201144_BIB22","doi-asserted-by":"crossref","unstructured":"Gao, B. and Tsan, M.-F. 2003. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor release by murine macrophages. J. Biol. Chem.278:174.","DOI":"10.1074\/jbc.M208742200"},{"key":"key\n\t\t\t\t20171010201144_BIB23","doi-asserted-by":"crossref","unstructured":"Bausinger, H., Lipsker, D., Ziylan, U. et al.2002. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol.32:3708.","DOI":"10.1002\/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C"},{"key":"key\n\t\t\t\t20171010201144_BIB24","doi-asserted-by":"crossref","unstructured":"Cheng, W., Hung, C., Lin, K. et al.2003. CD8+ T cells, NK cells and IFN-gamma are important for control of tumor with downregulated MHC class I expression by DNA vaccination. Gene Ther.10:1311.","DOI":"10.1038\/sj.gt.3301982"},{"key":"key\n\t\t\t\t20171010201144_BIB25","doi-asserted-by":"crossref","unstructured":"Huang, Q., Richmond, J. F. L., Suzue, K., Eisen, H. N. and Younga, R. A. 2000. In vivo cytotoxic T lymphocyte elicitation by mycobacterial heat shock protein 70 fusion proteins maps to a discrete domain and is CD4+ T cell independent. J. Exp. Med.191:403.","DOI":"10.1084\/jem.191.2.403"},{"key":"key\n\t\t\t\t20171010201144_BIB26","unstructured":"Chen, C.-H., Wang, T.-L., Hung, C.-F. et al.2000. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res.60:1035."},{"key":"key\n\t\t\t\t20171010201144_BIB27","doi-asserted-by":"crossref","unstructured":"Schirmbeck, R., Fissolo, N., Chaplin, P. and Reimann, J. 2003. Enhanced priming of multispecific, murine CD8+ T cell responses by DNA vaccines expressing stress protein-binding polytope peptides. J. Immunol.171:1240.","DOI":"10.4049\/jimmunol.171.3.1240"},{"key":"key\n\t\t\t\t20171010201144_BIB28","doi-asserted-by":"crossref","unstructured":"Sette, A. D., Oseroff, C., Sidney, J. et al.2001. Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice. J. Immunol.166:1389.","DOI":"10.4049\/jimmunol.166.2.1389"},{"key":"key\n\t\t\t\t20171010201144_BIB29","doi-asserted-by":"crossref","unstructured":"Schirmbeck, R., Zheng, X., Roggendorf, M. et al.2001. Targeting murine immune responses to selected T cell- or antibody-defined determinants of the hepatitis B surface antigen by plasmid DNA vaccines encoding chimeric antigen. J. Immunol.166:1405.","DOI":"10.4049\/jimmunol.166.2.1405"},{"key":"key\n\t\t\t\t20171010201144_BIB30","doi-asserted-by":"crossref","unstructured":"Wei, W.-Z., Ratner, S., Shibuya, T., Yoo, G. and Jani, A. 2001. Foreign antigenic peptides delivered to the tumor as targets of cytotoxic T cells. J. Immunol. Methods258:141.","DOI":"10.1016\/S0022-1759(01)00484-7"},{"key":"key\n\t\t\t\t20171010201144_BIB31","doi-asserted-by":"crossref","unstructured":"Livingston, B. D., Newman, M., Crimi, C., McKinney, D., Chesnut, R. and Sette, A. 2001. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine19:4652.","DOI":"10.1016\/S0264-410X(01)00233-X"},{"key":"key\n\t\t\t\t20171010201144_BIB32","doi-asserted-by":"crossref","unstructured":"Thomson, S. A., Sherritt, M. A., Medveczky, J. et al.1998. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J. Immunol.160:1717.","DOI":"10.4049\/jimmunol.160.4.1717"},{"key":"key\n\t\t\t\t20171010201144_BIB33","doi-asserted-by":"crossref","unstructured":"Livingston, B., Crimi, C., Newman, M. et al.2002. A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes. J. Immunol.168:5499.","DOI":"10.4049\/jimmunol.168.11.5499"},{"key":"key\n\t\t\t\t20171010201144_BIB34","doi-asserted-by":"crossref","unstructured":"Schirmbeck, R., Stober, D., Kholy, S. E., Riedl, P. and Reimann, J. 2002. The immunodominant, Ld-restricted T cell response to hepatitis B surface antigen (HBsAg) efficiently suppresses T cell priming to multiple Dd-, Kd-, and Kb-restricted HBsAg epitopes. J. Immunol.168:6253.","DOI":"10.4049\/jimmunol.168.12.6253"},{"key":"key\n\t\t\t\t20171010201144_BIB35","doi-asserted-by":"crossref","unstructured":"Chow, Y.-H., Chiang, B.-L., Lee, Y.-L. et al.1998. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol.160:1320.","DOI":"10.4049\/jimmunol.160.3.1320"},{"key":"key\n\t\t\t\t20171010201144_BIB36","doi-asserted-by":"crossref","unstructured":"Lipsker, D., Ziylan, U., Spehner, D. et al.2002. Heat shock proteins 70 and 60 share common receptors which are expressed on human monocyte-derived but not epidermal dendritic cells. Eur. J. Immunol.32:322.","DOI":"10.1002\/1521-4141(200202)32:2<322::AID-IMMU322>3.0.CO;2-0"},{"key":"key\n\t\t\t\t20171010201144_BIB37","doi-asserted-by":"crossref","unstructured":"Basu, S., Binder, R., Ramalingam, T. and Srivastava, P. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity14:303.","DOI":"10.1016\/S1074-7613(01)00111-X"},{"key":"key\n\t\t\t\t20171010201144_BIB38","doi-asserted-by":"crossref","unstructured":"Mancini, M., Hadchouel, M., Tiollais, P. and Michel, M.-L. 1998. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-secreting T cells after DNA-based immunization. J. Immunol.161:5564.","DOI":"10.4049\/jimmunol.161.10.5564"},{"key":"key\n\t\t\t\t20171010201144_BIB39","doi-asserted-by":"crossref","unstructured":"Whalley, S. A., Brown, D., Webster, G. J. et al.2004. Evolution of hepatitis B virus during primary infection in humans: transient generation of cytotoxic T-cell mutants. Gastroenterology127:1131.","DOI":"10.1053\/j.gastro.2004.07.004"}],"container-title":["International Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/intimm\/article-pdf\/17\/10\/1293\/2466568\/dxh305.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:34:08Z","timestamp":1683185648000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/intimm\/article\/17\/10\/1293\/827180\/A-novel-HBV-DNA-vaccine-based-on-T-cell-epitopes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,19]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2005,8,19]]},"published-print":{"date-parts":[[2005,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/intimm\/dxh305","relation":{},"ISSN":["1460-2377","0953-8178"],"issn-type":[{"value":"1460-2377","type":"electronic"},{"value":"0953-8178","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,10]]},"published":{"date-parts":[[2005,8,19]]}}}